Similar articles for PMID: 9647301

Year	Number of Results
1968	1
1985	1
1988	1
1989	1
1992	1
1993	2
1994	2
1995	2
1996	5
1997	2
1998	6
1999	6
2000	3
2001	1
2002	5
2003	1
2004	5
2005	3
2006	1
2007	1
2008	1
2009	2
2010	4
2011	1
2012	3
2013	4
2014	7
2015	1
2016	3
2017	6
2018	6
2019	2
2024	0

1

Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis.

Edwards S, Zvartau M, Clarke H, Irving W, Blumhardt LD. Edwards S, et al. J Neurol Neurosurg Psychiatry. 1998 Jun;64(6):736-41. doi: 10.1136/jnnp.64.6.736. J Neurol Neurosurg Psychiatry. 1998. PMID: 9647301 Free PMC article. Clinical Trial.

2

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).

Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Granger CV, Simon JH, Alam JJ, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munschauer FE 3rd, Priore RL, Pullicino PM, Scherokman BJ, Whitham RH, et al. Jacobs LD, et al. Ann Neurol. 1996 Mar;39(3):285-94. doi: 10.1002/ana.410390304. Ann Neurol. 1996. PMID: 8602746 Clinical Trial.

3

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.

Pozzilli C, Bastianello S, Koudriavtseva T, Gasperini C, Bozzao A, Millefiorini E, Galgani S, Buttinelli C, Perciaccante G, Piazza G, Bozzao L, Fieschi C. Pozzilli C, et al. J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):251-8. doi: 10.1136/jnnp.61.3.251. J Neurol Neurosurg Psychiatry. 1996. PMID: 8795595 Free PMC article. Clinical Trial.

4

Prospective study on the relationship between infections and multiple sclerosis exacerbations.

Buljevac D, Flach HZ, Hop WC, Hijdra D, Laman JD, Savelkoul HF, van Der Meché FG, van Doorn PA, Hintzen RQ. Buljevac D, et al. Brain. 2002 May;125(Pt 5):952-60. doi: 10.1093/brain/awf098. Brain. 2002. PMID: 11960885 Free article.

5

Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis.

Arnold DL, Calabresi PA, Kieseier BC, Sheikh SI, Deykin A, Zhu Y, Liu S, You X, Sperling B, Hung S. Arnold DL, et al. BMC Neurol. 2014 Dec 31;14:240. doi: 10.1186/s12883-014-0240-x. BMC Neurol. 2014. PMID: 25551571 Free PMC article. Clinical Trial.

6

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.

Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW. Jacobs LD, et al. N Engl J Med. 2000 Sep 28;343(13):898-904. doi: 10.1056/NEJM200009283431301. N Engl J Med. 2000. PMID: 11006365 Free article. Clinical Trial.

7

Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial.

Arnold DL, Calabresi PA, Kieseier BC, Liu S, You X, Fiore D, Hung S. Arnold DL, et al. BMC Neurol. 2017 Feb 10;17(1):29. doi: 10.1186/s12883-017-0799-0. BMC Neurol. 2017. PMID: 28183276 Free PMC article. Clinical Trial.

8

Serum soluble intercellular adhesion molecule-I in MS: relation to clinical and Gd-MRI activity and to rIFN beta-Ib treatment.

Trojano M, Avolio C, Ruggieri M, Defazio G, Giuliani F, Paolicelli D, Livrea P. Trojano M, et al. Mult Scler. 1998 Jun;4(3):183-7. doi: 10.1177/135245859800400318. Mult Scler. 1998. PMID: 9762671 Clinical Trial.

9

Defining interferon beta response status in multiple sclerosis patients.

Rudick RA, Lee JC, Simon J, Ransohoff RM, Fisher E. Rudick RA, et al. Ann Neurol. 2004 Oct;56(4):548-55. doi: 10.1002/ana.20224. Ann Neurol. 2004. PMID: 15389896 Clinical Trial.

10

MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies.

McFarland HF, Stone LA, Calabresi PA, Maloni H, Bash CN, Frank JA. McFarland HF, et al. Mult Scler. 1996 Nov;2(4):198-205. doi: 10.1177/135245859600200406. Mult Scler. 1996. PMID: 9345374 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

83 results

Results by year